BindingDB logo
myBDB logout

Patent code US9546152

Compile Data Set for Download or QSAR

Found 448 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Orexin receptor 2


(Homo sapiens (Human))
BDBM205137
PNG
(3-methyl-2-{[(3r,6r)-6- methyl-1-{[2-(1,3-thiazol-...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1nccs1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C23H22N4O2S/c1-15-7-8-18(29-21-16(2)17(13-24)9-10-25-21)14-27(15)23(28)20-6-4-3-5-19(20)22-26-11-12-30-22/h3-6,9-12,15,18H,7-8,14H2,1-2H3/t15-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205119
PNG
(2-{[(3r,6r)-1-{[5-fluoro-2- (1,3-thiazol-2- yl)phe...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1cc(F)ccc1-c1nccs1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C23H21FN4O2S/c1-14-3-5-18(30-21-15(2)16(12-25)7-8-26-21)13-28(14)23(29)20-11-17(24)4-6-19(20)22-27-9-10-31-22/h4,6-11,14,18H,3,5,13H2,1-2H3/t14-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205245
PNG
(3-ethyl-2-{[(3r,6r)-6- methyl-1-{[2-(2h-1,2,3- tri...)
Show SMILES CCc1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)nccc1C#N
Show InChI InChI=1S/C23H24N6O2/c1-3-19-17(14-24)10-11-25-22(19)31-18-9-8-16(2)28(15-18)23(30)20-6-4-5-7-21(20)29-26-12-13-27-29/h4-7,10-13,16,18H,3,8-9,15H2,1-2H3/t16-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205260
PNG
(US9546152, example 95)
Show SMILES CSc1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)nccc1C#N
Show InChI InChI=1S/C22H22N6O2S/c1-15-7-8-17(30-21-20(31-2)16(13-23)9-10-24-21)14-27(15)22(29)18-5-3-4-6-19(18)28-25-11-12-26-28/h3-6,9-12,15,17H,7-8,14H2,1-2H3/t15-,17-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205108
PNG
(2-{[(3r,6r)-1-{[2-fluoro-6- (1,3-thiazol-2- yl)phe...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1c(F)cccc1-c1nccs1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C23H21FN4O2S/c1-14-6-7-17(30-21-15(2)16(12-25)8-9-26-21)13-28(14)23(29)20-18(4-3-5-19(20)24)22-27-10-11-31-22/h3-5,8-11,14,17H,6-7,13H2,1-2H3/t14-,17-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205105
PNG
(3-methyl-2-{[(3r,6r)-6- methyl-1-{[2-methyl-6-(2h-...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1c(C)cccc1-n1nccn1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C23H24N6O2/c1-15-5-4-6-20(29-26-11-12-27-29)21(15)23(30)28-14-19(8-7-16(28)2)31-22-17(3)18(13-24)9-10-25-22/h4-6,9-12,16,19H,7-8,14H2,1-3H3/t16-,19-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.200n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205104
PNG
(2-{[(3r,6r)-1-{[2-methoxy-6- (2h-1,2,3-triazol-2- ...)
Show SMILES COc1cccc(c1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccc(C#N)c1C)-n1nccn1
Show InChI InChI=1S/C23H24N6O3/c1-15-7-8-18(32-22-16(2)17(13-24)9-10-25-22)14-28(15)23(30)21-19(29-26-11-12-27-29)5-4-6-20(21)31-3/h4-6,9-12,15,18H,7-8,14H2,1-3H3/t15-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.200n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205244
PNG
(US9546152, example 92)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccc(C#N)c1C1CC1
Show InChI InChI=1S/C24H24N6O2/c1-16-6-9-19(32-23-22(17-7-8-17)18(14-25)10-11-26-23)15-29(16)24(31)20-4-2-3-5-21(20)30-27-12-13-28-30/h2-5,10-13,16-17,19H,6-9,15H2,1H3/t16-,19-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.200n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205124
PNG
(3-methyl-2-{[(3r,6r)-6- methyl-1-{[2-(1,3-thiazol-...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1cscn1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C23H22N4O2S/c1-15-7-8-18(29-22-16(2)17(11-24)9-10-25-22)12-27(15)23(28)20-6-4-3-5-19(20)21-13-30-14-26-21/h3-6,9-10,13-15,18H,7-8,12H2,1-2H3/t15-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.200n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205125
PNG
(2-{[(3r,6r)-1-{[4-fluoro-2- (1,3-thiazol-2- yl)phe...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccc(F)cc1-c1nccs1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C23H21FN4O2S/c1-14-3-5-18(30-21-15(2)16(12-25)7-8-26-21)13-28(14)23(29)19-6-4-17(24)11-20(19)22-27-9-10-31-22/h4,6-11,14,18H,3,5,13H2,1-2H3/t14-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.200n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM206334
PNG
(2-({(3r,6r)-1-[(2- cyclobutylphenyl)carbonyl]- 6-m...)
Show SMILES COc1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2C2CCC2)nccc1C#N
Show InChI InChI=1S/C24H27N3O3/c1-16-10-11-19(30-23-22(29-2)18(14-25)12-13-26-23)15-27(16)24(28)21-9-4-3-8-20(21)17-6-5-7-17/h3-4,8-9,12-13,16-17,19H,5-7,10-11,15H2,1-2H3/t16-,19-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.200n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205103
PNG
(3-methyl-2-{[(3r,6r)-6- methyl-1-{[3-methyl-2-(2h-...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1cccc(C)c1-n1nccn1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C23H24N6O2/c1-15-5-4-6-20(21(15)29-26-11-12-27-29)23(30)28-14-19(8-7-16(28)2)31-22-17(3)18(13-24)9-10-25-22/h4-6,9-12,16,19H,7-8,14H2,1-3H3/t16-,19-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.200n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205126
PNG
(2-{[(3r,6r)-1-{[5-fluoro-2- (1,3-thiazol-2-yl)pyri...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1cc(F)cnc1-c1nccs1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C22H20FN5O2S/c1-13-3-4-17(30-20-14(2)15(10-24)5-6-25-20)12-28(13)22(29)18-9-16(23)11-27-19(18)21-26-7-8-31-21/h5-9,11,13,17H,3-4,12H2,1-2H3/t13-,17-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.300n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205112
PNG
(2-{[(3r,6r)-1-{[2-fluoro-6- (1,3-thiazol-4- yl)phe...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1c(F)cccc1-c1cscn1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C23H21FN4O2S/c1-14-6-7-17(30-22-15(2)16(10-25)8-9-26-22)11-28(14)23(29)21-18(4-3-5-19(21)24)20-12-31-13-27-20/h3-5,8-9,12-14,17H,6-7,11H2,1-2H3/t14-,17-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.300n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM206340
PNG
(2-({(3r,6r)-1-[(5-fluoro-2- pyrimidin-2- ylphenyl)...)
Show SMILES COc1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-c2ncccn2)nccc1C#N
Show InChI InChI=1S/C24H22FN5O3/c1-15-4-6-18(33-23-21(32-2)16(13-26)8-11-29-23)14-30(15)24(31)20-12-17(25)5-7-19(20)22-27-9-3-10-28-22/h3,5,7-12,15,18H,4,6,14H2,1-2H3/t15-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.300n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205101
PNG
(2-{[(3r,6r)-1-{[2-fluoro-6- (2h-1,2,3-triazol-2- y...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1c(F)cccc1-n1nccn1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C22H21FN6O2/c1-14-6-7-17(31-21-15(2)16(12-24)8-9-25-21)13-28(14)22(30)20-18(23)4-3-5-19(20)29-26-10-11-27-29/h3-5,8-11,14,17H,6-7,13H2,1-2H3/t14-,17-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.300n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205349
PNG
(US9546152, example 97)
Show SMILES COc1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(F)c2-n2nccn2)nccc1C#N
Show InChI InChI=1S/C22H21FN6O3/c1-14-6-7-16(32-21-20(31-2)15(12-24)8-9-25-21)13-28(14)22(30)17-4-3-5-18(23)19(17)29-26-10-11-27-29/h3-5,8-11,14,16H,6-7,13H2,1-2H3/t14-,16-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.300n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205345
PNG
(US9546152, example 96)
Show SMILES COc1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)nccc1C#N
Show InChI InChI=1S/C22H22N6O3/c1-15-7-8-17(31-21-20(30-2)16(13-23)9-10-24-21)14-27(15)22(29)18-5-3-4-6-19(18)28-25-11-12-26-28/h3-6,9-12,15,17H,7-8,14H2,1-2H3/t15-,17-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.300n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205986
PNG
(3-methoxy-2-{[(3r,6r)-6- methyl-1-{[3-methyl-2-(2h...)
Show SMILES COc1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(C)c2-n2nccn2)nccc1C#N
Show InChI InChI=1S/C23H24N6O3/c1-15-5-4-6-19(20(15)29-26-11-12-27-29)23(30)28-14-18(8-7-16(28)2)32-22-21(31-3)17(13-24)9-10-25-22/h4-6,9-12,16,18H,7-8,14H2,1-3H3/t16-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.300n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205118
PNG
(3-methyl-2-{[(3r,6r)-6- methyl-1-{[2-(1,3-oxazol-2...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncco1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C23H22N4O3/c1-15-7-8-18(30-21-16(2)17(13-24)9-10-25-21)14-27(15)23(28)20-6-4-3-5-19(20)22-26-11-12-29-22/h3-6,9-12,15,18H,7-8,14H2,1-2H3/t15-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.300n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205898
PNG
(2-{[(3r,6r)-1-{[2-fluoro-6- (2h-1,2,3-triazol-2- y...)
Show SMILES COc1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-n2nccn2)nccc1C#N
Show InChI InChI=1S/C22H21FN6O3/c1-14-6-7-16(32-21-20(31-2)15(12-24)8-9-25-21)13-28(14)22(30)19-17(23)4-3-5-18(19)29-26-10-11-27-29/h3-5,8-11,14,16H,6-7,13H2,1-2H3/t14-,16-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.300n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205352
PNG
(2-{[(3r,6r)-1-{[4-fluoro-2- (2h-1,2,3-triazol-2- y...)
Show SMILES COc1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-n2nccn2)nccc1C#N
Show InChI InChI=1S/C22H21FN6O3/c1-14-3-5-17(32-21-20(31-2)15(12-24)7-8-25-21)13-28(14)22(30)18-6-4-16(23)11-19(18)29-26-9-10-27-29/h4,6-11,14,17H,3,5,13H2,1-2H3/t14-,17-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.300n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205180
PNG
(US9546152, example 74)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C24H23N5O2/c1-16-8-9-19(31-23-17(2)18(14-25)10-13-28-23)15-29(16)24(30)21-7-4-3-6-20(21)22-26-11-5-12-27-22/h3-7,10-13,16,19H,8-9,15H2,1-2H3/t16-,19-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.300n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM206336
PNG
(3-methoxy-2- ({(3r,6r)-6-methyl-1- [(2-pyrimidin-2...)
Show SMILES COc1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2ncccn2)nccc1C#N
Show InChI InChI=1S/C24H23N5O3/c1-16-8-9-18(32-23-21(31-2)17(14-25)10-13-28-23)15-29(16)24(30)20-7-4-3-6-19(20)22-26-11-5-12-27-22/h3-7,10-13,16,18H,8-9,15H2,1-2H3/t16-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.400n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM206341
PNG
(2-({(3r,6r)-1-[(2-fluoro-2- pyrimidin-2- ylphenyl)...)
Show SMILES COc1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-c2ncccn2)nccc1C#N
Show InChI InChI=1S/C24H22FN5O3/c1-15-7-8-17(33-23-21(32-2)16(13-26)9-12-29-23)14-30(15)24(31)20-18(5-3-6-19(20)25)22-27-10-4-11-28-22/h3-6,9-12,15,17H,7-8,14H2,1-2H3/t15-,17-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.400n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205651
PNG
(2-{[(3r,6r)-1-{[5-fluoro-2- (2h-1,2,3-triazol-2- y...)
Show SMILES COc1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-n2nccn2)nccc1C#N
Show InChI InChI=1S/C22H21FN6O3/c1-14-3-5-17(32-21-20(31-2)15(12-24)7-8-25-21)13-28(14)22(30)18-11-16(23)4-6-19(18)29-26-9-10-27-29/h4,6-11,14,17H,3,5,13H2,1-2H3/t14-,17-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.400n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM206332
PNG
(3-methoxy-2-{[(3r,6r)-6- methyl-1-{[5-methyl-2-(2h...)
Show SMILES COc1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(C)ccc2-n2nccn2)nccc1C#N
Show InChI InChI=1S/C23H24N6O3/c1-15-4-7-20(29-26-10-11-27-29)19(12-15)23(30)28-14-18(6-5-16(28)2)32-22-21(31-3)17(13-24)8-9-25-22/h4,7-12,16,18H,5-6,14H2,1-3H3/t16-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.400n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM202473
PNG
(US9546152, example 1)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C22H22N6O2/c1-15-7-8-18(30-21-16(2)17(13-23)9-10-24-21)14-27(15)22(29)19-5-3-4-6-20(19)28-25-11-12-26-28/h3-6,9-12,15,18H,7-8,14H2,1-2H3/t15-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.400n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM206330
PNG
(3-methoxy-2-{[(3r,6r)-6- methyl-1-{[4-methyl-2-(2h...)
Show SMILES COc1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(C)cc2-n2nccn2)nccc1C#N
Show InChI InChI=1S/C23H24N6O3/c1-15-4-7-19(20(12-15)29-26-10-11-27-29)23(30)28-14-18(6-5-16(28)2)32-22-21(31-3)17(13-24)8-9-25-22/h4,7-12,16,18H,5-6,14H2,1-3H3/t16-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.400n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM203393
PNG
(2-{[(3r,6r)-1-{[4-chloro-2- (2h-1,2,3-triazol-2- y...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccc(Cl)cc1-n1nccn1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C22H21ClN6O2/c1-14-3-5-18(31-21-15(2)16(12-24)7-8-25-21)13-28(14)22(30)19-6-4-17(23)11-20(19)29-26-9-10-27-29/h4,6-11,14,18H,3,5,13H2,1-2H3/t14-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.400n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205154
PNG
(3-methyl-2-{[(3r,6r)-6- methyl-1-{[2-(3-methyl-1,2...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1nc(C)no1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C23H23N5O3/c1-14-8-9-18(30-21-15(2)17(12-24)10-11-25-21)13-28(14)23(29)20-7-5-4-6-19(20)22-26-16(3)27-31-22/h4-7,10-11,14,18H,8-9,13H2,1-3H3/t14-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.5n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205099
PNG
(2-{[(3r,6r)-1-{[4-fluoro-2- (2h-1,2,3-triazol-2- y...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccc(F)cc1-n1nccn1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C22H21FN6O2/c1-14-3-5-18(31-21-15(2)16(12-24)7-8-25-21)13-28(14)22(30)19-6-4-17(23)11-20(19)29-26-9-10-27-29/h4,6-11,14,18H,3,5,13H2,1-2H3/t14-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.5n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205142
PNG
(2-{[(3r,6r)-1-{[2-(6- methoxypyridin-3- yl)phenyl]...)
Show SMILES COc1ccc(cn1)-c1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C26H26N4O3/c1-17-8-10-21(33-25-18(2)19(14-27)12-13-28-25)16-30(17)26(31)23-7-5-4-6-22(23)20-9-11-24(32-3)29-15-20/h4-7,9,11-13,15,17,21H,8,10,16H2,1-3H3/t17-,21-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.5n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205144
PNG
(2-({(3r,6r)-1-[(2-cyclopropyl- 4-methylphenyl)carb...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccc(C)cc1C1CC1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C24H27N3O2/c1-15-4-9-21(22(12-15)18-6-7-18)24(28)27-14-20(8-5-16(27)2)29-23-17(3)19(13-25)10-11-26-23/h4,9-12,16,18,20H,5-8,14H2,1-3H3/t16-,20-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.600n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM203422
PNG
(3-methyl-2-{[(3r,6r)-6- methyl-1-{[5-methyl-2-(2h-...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1cc(C)ccc1-n1nccn1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C23H24N6O2/c1-15-4-7-21(29-26-10-11-27-29)20(12-15)23(30)28-14-19(6-5-16(28)2)31-22-17(3)18(13-24)8-9-25-22/h4,7-12,16,19H,5-6,14H2,1-3H3/t16-,19-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.600n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205185
PNG
(3-methyl-2-({(3r,6r)-6- methyl-1-[(2-pyrimidin-2- ...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C22H21N5O2S/c1-14-4-5-17(29-21-15(2)16(12-23)6-10-26-21)13-27(14)22(28)18-7-11-30-19(18)20-24-8-3-9-25-20/h3,6-11,14,17H,4-5,13H2,1-2H3/t14-,17-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.600n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205166
PNG
(2-{[(3r,6r)-1-{[5-fluoro-2- (2h-1,2,3-triazol-2- y...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1cc(F)ccc1-n1nccn1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C22H21FN6O2/c1-14-3-5-18(31-21-15(2)16(12-24)7-8-25-21)13-28(14)22(30)19-11-17(23)4-6-20(19)29-26-9-10-27-29/h4,6-11,14,18H,3,5,13H2,1-2H3/t14-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.600n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205132
PNG
(3-methyl-2-{[(3r,6r)-6- methyl-1-{[2-(5-methyl-2h-...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nnc(C)n1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C22H23N7O2/c1-14-8-9-18(31-21-15(2)17(12-23)10-11-24-21)13-28(14)22(30)19-6-4-5-7-20(19)29-26-16(3)25-27-29/h4-7,10-11,14,18H,8-9,13H2,1-3H3/t14-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.600n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205111
PNG
(3-methyl-2-{[(3r,6r)-6- methyl-1-{[2-(1- methyleth...)
Show SMILES CC(C)Oc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C23H27N3O3/c1-15(2)28-21-8-6-5-7-20(21)23(27)26-14-19(10-9-16(26)3)29-22-17(4)18(13-24)11-12-25-22/h5-8,11-12,15-16,19H,9-10,14H2,1-4H3/t16-,19-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.600n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM204068
PNG
(3-methyl-2-{[(3r,6r)-6- methyl-1-{[4-methyl-2-(2h-...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccc(C)cc1-n1nccn1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C23H24N6O2/c1-15-4-7-20(21(12-15)29-26-10-11-27-29)23(30)28-14-19(6-5-16(28)2)31-22-17(3)18(13-24)8-9-25-22/h4,7-12,16,19H,5-6,14H2,1-3H3/t16-,19-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.600n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM206339
PNG
(2-({(3r,6r)-1-[(4-fluoro-2- pyrimidin-2- ylphenyl)...)
Show SMILES COc1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-c2ncccn2)nccc1C#N
Show InChI InChI=1S/C24H22FN5O3/c1-15-4-6-18(33-23-21(32-2)16(13-26)8-11-29-23)14-30(15)24(31)19-7-5-17(25)12-20(19)22-27-9-3-10-28-22/h3,5,7-12,15,18H,4,6,14H2,1-2H3/t15-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.600n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205117
PNG
(2-{[(3r,6r)-1-{[5-fluoro-2- (1,3-thiazol-4- yl)phe...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1cc(F)ccc1-c1cscn1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C23H21FN4O2S/c1-14-3-5-18(30-22-15(2)16(10-25)7-8-26-22)11-28(14)23(29)20-9-17(24)4-6-19(20)21-12-31-13-27-21/h4,6-9,12-14,18H,3,5,11H2,1-2H3/t14-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.600n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205106
PNG
(2-({(3r,6r)-1-[(2- cyclopropylphenyl)carbonyl]- 6-...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1CC1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C23H25N3O2/c1-15-7-10-19(28-22-16(2)18(13-24)11-12-25-22)14-26(15)23(27)21-6-4-3-5-20(21)17-8-9-17/h3-6,11-12,15,17,19H,7-10,14H2,1-2H3/t15-,19-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.700n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205131
PNG
(3-methyl-2-{[(3r,6r)-6- methyl-1-{[2-(2h-1,2,3- tr...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C20H20N6O2S/c1-13-3-4-16(28-18-14(2)15(11-21)5-7-22-18)12-25(13)19(27)17-6-10-29-20(17)26-23-8-9-24-26/h5-10,13,16H,3-4,12H2,1-2H3/t13-,16-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.700n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205123
PNG
(3-methyl-2-{[(3r,6r)-6- methyl-1-{[2-(1,3-thiazol-...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1nccs1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C21H20N4O2S2/c1-13-3-4-16(27-19-14(2)15(11-22)5-7-23-19)12-25(13)21(26)17-6-9-28-18(17)20-24-8-10-29-20/h5-10,13,16H,3-4,12H2,1-2H3/t13-,16-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.700n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205109
PNG
(2-({(3r,6r)-1-[(2- ethoxyphenyl)carbonyl]-6- methy...)
Show SMILES CCOc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C22H25N3O3/c1-4-27-20-8-6-5-7-19(20)22(26)25-14-18(10-9-15(25)2)28-21-16(3)17(13-23)11-12-24-21/h5-8,11-12,15,18H,4,9-10,14H2,1-3H3/t15-,18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.700n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205228
PNG
(US9546152, example 91)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccc(C#N)c1Cl
Show InChI InChI=1S/C21H19ClN6O2/c1-14-6-7-16(30-20-19(22)15(12-23)8-9-24-20)13-27(14)21(29)17-4-2-3-5-18(17)28-25-10-11-26-28/h2-5,8-11,14,16H,6-7,13H2,1H3/t14-,16-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.800n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205158
PNG
(3-methyl-2-{[(3r,6r)-6- methyl-1-{[2- (trifluorome...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1OC(F)(F)F)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C21H20F3N3O3/c1-13-7-8-16(29-19-14(2)15(11-25)9-10-26-19)12-27(13)20(28)17-5-3-4-6-18(17)30-21(22,23)24/h3-6,9-10,13,16H,7-8,12H2,1-2H3/t13-,16-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.800n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205122
PNG
(3-methyl-2-{[(3r,6r)-6- methyl-1-{[2-(1,3-thiazol-...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1cscn1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C21H20N4O2S2/c1-13-3-4-16(27-20-14(2)15(9-22)5-7-23-20)10-25(13)21(26)17-6-8-29-19(17)18-11-28-12-24-18/h5-8,11-13,16H,3-4,10H2,1-2H3/t13-,16-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.800n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Orexin receptor 2


(Homo sapiens (Human))
BDBM205182
PNG
(3-methyl-2-({(3r,6r)-6- methyl-1-[(3-pyrimidin-2- ...)
Show SMILES C[C@@H]1CC[C@H](CN1C(=O)c1sccc1-c1ncccn1)Oc1nccc(C#N)c1C
Show InChI InChI=1S/C22H21N5O2S/c1-14-4-5-17(29-21-15(2)16(12-23)6-10-26-21)13-27(14)22(28)19-18(7-11-30-19)20-24-8-3-9-25-20/h3,6-11,14,17H,4-5,13H2,1-2H3/t14-,17-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.800n/an/an/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.

US Patent


Assay Description
Radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430) in which the inhibition constant (Ki) is determ...


Citation and Details
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 448 total )  |  Next  |  Last  >>
* indicates data uncertainty>20%